Urinary concentration of transforming growth factor‐β‐inducible gene‐h3(βig‐h3) in patients with Type 2 diabetes mellitus
Authors:
- 2 December 2004
- journal article
- Published by Wiley in Diabetic Medicine
- Vol. 22 (1) , 14-20
Abstract
Aims The expression of TGFβ‐inducible gene h3(βig‐h3) has been used to assess the biological activity of TGFβ in the kidney. In this study, we investigated whether the urinary concentration of βig‐h3 is associated with diabetic nephropathy in patients with Type 2 diabetes mellitus. We also evaluated the relationship between the urinary concentration of βig‐3 and proteinuria and microalbuminuria (AER) in a normal healthy population and in Type 2 diabetes patients.Methods Four hundred and seventy‐nine Type 2 diabetic patients without non‐diabetic kidney diseases and 528 healthy control subjects were enrolled. The study subjects were divided into five groups: a non‐diabetic healthy control group with normal ACR (n = 443), a non‐diabetic healthy control group with microalbuminuria (n = 85), a normoalbuminuric diabetic group (n = 198), a microalbuminuric diabetic group (n = 155) and an overt proteinuria group (n = 126). Urinary levels of βig‐h3 were measured by enzyme‐linked immunosorbent assay.Results (i) Urinary excretion of βig‐h3 was significantly higher in the diabetic groups than in the controls, even in the normoalbuminuric stage (25.02 ± 8.84 vs. 18.67 ± 6.56, P = 0.03). In diabetic patients, urinary βig‐h3 levels increased significantly as diabetic nephropathy advanced (25.02 ± 8.84 vs. 34.06 ± 24.55 vs. 169.63 ± 57.33, P < 0.001). (ii) Proteinuria was found to be significantly correlated with urinary βig‐h3 (healthy control; r = 0.137, P = 0.019, diabetic patients; r = 0.604, P < 0.001). ACR was also found to be significantly related with urinary βig‐h3 in diabetic patients (r = 0.383, P = 0.006). (iii) In diabetic patients, urinary βig‐h3 was significantly related with systolic and diastolic blood pressure (systolic blood pressure: r = 0.436, P = 0.024; diastolic blood pressure, r = 0.365, P = 0.042), total cholesterol and HbA1c (cholesterol: r = 0.169, P = 0.03, HbA1c; r = 0.387, P = 0.044). Logistic regression analyses showed that urinary βig‐h3 was associated with a significant increase in the risk of microalbuminuria and proteinuria in diabetic patients.Conclusions Longitudinal monitoring of urinary βig‐h3 may improve the likelihood of detecting diabetic nephropathy at an earlier stage and βig‐h3 could be a sensitive marker of diabetic kidney disease progression.Keywords
This publication has 24 references indexed in Scilit:
- TGF‐β‐induced protein βig‐h3 is upregulated by high glucose in vascular smooth muscle cellsJournal of Cellular Biochemistry, 2002
- Report of the Expert Committee on the Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2002
- Nephropathy in Patients with Type 2 Diabetes MellitusNew England Journal of Medicine, 1999
- Expression of different isoforms of TGF-β and the latent TGF-β binding protein (LTBP) by rat Kupffer cellsJournal of Hepatology, 1998
- Transforming growth factor‐β (TGF‐β) activity in urine of patients with glomerulonephritis is related to their renal functional and structural changesNephrology, 1998
- βig-h3, a Transforming Growth Factor–β–Inducible Gene, Is Overexpressed in Atherosclerotic and Restenotic Human Vascular LesionsArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Urine Transforming Growth Factor-β Activity is Related to the Degree of Scarring in Crescentic Nephritis in the RabbitNephron, 1993
- Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney diseaseNature, 1992
- cDNA Cloning and Sequence Analysis of βig-h3, a Novel Gene Induced in a Human Adenocarcinoma Cell Line after Treatment with Transforming Growth Factor-βDNA and Cell Biology, 1992
- The Transforming Growth Factor-beta FamilyAnnual Review of Cell Biology, 1990